Kingdom Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Kingdom Therapeutics General Information

Description

Developer of autism spectrum disorder (ASD) drugs intended to create a link between the gut, the brain, and the endocannabinoid system. The company's cannabinoid based treatment utilises a delivery methodology that improves bioavailability and, by bypassing the liver, has the potential to reduce adverse effects, enabling ASD children to improve both behavioural and gastrointestinal symptoms in ASD.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ireland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Ireland

Kingdom Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kingdom Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 29-Jan-2025 Completed Clinical Trials - Phase 1
2. Early Stage VC 07-Jul-2023 Completed Startup
1. Seed Round 07-Jun-2021 $283K $283K Completed Startup
To view Kingdom Therapeutics’s complete valuation and funding history, request access »

Kingdom Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Kingdom Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kingdom Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kingdom Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
5 Horizons Capital Venture Capital Minority
Celadon Pharmaceuticals Corporation Minority
To view Kingdom Therapeutics’s complete investors history, request access »

Kingdom Therapeutics FAQs

  • When was Kingdom Therapeutics founded?

    Kingdom Therapeutics was founded in 2019.

  • Where is Kingdom Therapeutics headquartered?

    Kingdom Therapeutics is headquartered in Ireland.

  • What is the size of Kingdom Therapeutics?

    Kingdom Therapeutics has 9 total employees.

  • What industry is Kingdom Therapeutics in?

    Kingdom Therapeutics’s primary industry is Drug Discovery.

  • Is Kingdom Therapeutics a private or public company?

    Kingdom Therapeutics is a Private company.

  • What is Kingdom Therapeutics’s current revenue?

    The current revenue for Kingdom Therapeutics is .

  • How much funding has Kingdom Therapeutics raised over time?

    Kingdom Therapeutics has raised $942K.

  • Who are Kingdom Therapeutics’s investors?

    5 Horizons Capital and Celadon Pharmaceuticals have invested in Kingdom Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process